Vaccine candidates for Ebola, other filoviruses show promise
UH researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
Ebola vaccine developed by UH can withstand high heat
Developed by UH Mānoa scientist Axel Lehrer, the vaccine remains viable in extreme heat conditions for several months, which is especially important where the disease outbreaks so far have begun in rural, spread-out areas of hot, dry West Africa.
Ebola virus research in Liberia part of Kapiʻolani CC professor’s mission
In summer2018, John Berestecky accompanied three UH students to help with Ebola and Lassa virus research at the University of Liberia in Monrovia.
UH Mānoa scientists part of a $6 million grant to investigate aquatic viruses
Oceanographers Grieg Steward and Kyle Edwards received a National Science Foundation grant to probe how viruses impact microbes critical to our lives—from producing oxygen to growing food.
Nearly $6.3M grant to expand promising Ebola vaccine research awarded to UH researcher
Axel Lehrer will test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
ARCS Honolulu Scientist of the Year speaks on hantaviruses
Richard Yanagihara, an expert in emerging diseases, will discuss Hantaviruses: A Personal Journey of Discovery and New Beginnings at a free talk on September 14.
Viruses in the oceanic basement
UH Mānoa researchers provide evidence that the viruses are actively infecting the many unusual microorganisms that live deep in the rocky crust of the seafloor.
